Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-09 04:26 | 2025-12-04 | EOSE | Eos Energy Enterprises, Inc. | Bornstein Jeffrey S | Director | Miscellaneous Electrical Machinery, Equipment & Supplies | SALE | $15.19 | 40,328 | $612,538 | 0 | -100.0% |
| 2024-09-17 02:09 | 2024-09-12 | EOSE | Eos Energy Enterprises, Inc. | Bornstein Jeffrey S | Director | Miscellaneous Electrical Machinery, Equipment & Supplies | SALE | $2.63 | 162,720 | $427,661 | 84,929 | -65.7% |
| 2022-11-14 16:56 | 2022-11-10 | EOSE | Eos Energy Enterprises, Inc. | Bornstein Jeffrey S | Director | Miscellaneous Electrical Machinery, Equipment & Supplies | BUY | $1.30 | 20,000 | $25,936 | 20,000 | +100.0% |
| 2022-04-28 14:46 | 2022-04-26 | ALVR | Kalaris Therapeutics, Inc. | Bornstein Jeffrey S | Director | Biological Products, (No Diagnostic Substances) | BUY | $4.64 | 5,000 | $23,197 | 40,197 | +14.2% |
| 2022-02-11 01:03 | 2022-02-10 | ALVR | Kalaris Therapeutics, Inc. | Bornstein Jeffrey S | Director | Biological Products, (No Diagnostic Substances) | BUY | $8.87 | 5,000 | $44,350 | 35,197 | +16.6% |
| 2021-02-24 03:57 | 2021-02-18 | ALVR | Kalaris Therapeutics, Inc. | Bornstein Jeffrey S | Director | Biological Products, (No Diagnostic Substances) | SALE | $40.43 | 20,583 | $832,119 | 0 | -100.0% |
| 2017-02-03 00:10 | 2017-01-31 | GE | GENERAL ELECTRIC CO | Bornstein Jeffrey S | Officer; Senior Vice President | Electronic & Other Electrical Equipment (No Computer Equip) | BUY | $29.63 | 5,000 | $148,150 | 68,757 | +7.8% |
| 2016-02-06 00:07 | 2016-02-03 | GE | GENERAL ELECTRIC CO | Bornstein Jeffrey S | Officer; Senior Vice President | Electronic & Other Electrical Equipment (No Computer Equip) | OPT+S | $28.91 | 168,313 | $4,865,256 | 50,355 | -77.0% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.